Inhibition by CO of hepatic benzo[a]pyrene hydroxylation and its reversal by monochromatic light. 1977

D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney

Inhibition by CO of benzo[a]pyrene hydroxylation was studied in hepatic microsomes from rats pretreated with phenobarbital, 3-methylcholanthrene or 2,3,7,8-tetrachlorodibenzo-p-dioxin, from animals treated with vehicle (saline or corn oil, respectively), and in a reconstituted microsomal cytochrome P-448 system prepared from rats treated with 3-methylcholanthrene. In all preparations the hydroxylation was inhibited by CO, and this inhibition was most effectively reversed by irradiation with monochromatic light of 450 nm wavelength. These observations provide direct evidence that the oxygen-activating component of all the examined benzo[a]pyrene hydroxylase systems is a P-450-type heme protein. The only striking difference observed in these systems was the low CO sensitivity of the benzo[a]pyrene hydroxylase reaction in microsomes from animals treated with 3-methylcholanthrene or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Half-maximal inhibition occurred at CO/O2 ratios of 9--12, rather than at 1--2, which is the usual range for P-450-linked mixed-function oxidase reactions. In contrast, the reconstituted benzo[a]pyrene hydroxylase system, with purified cytochrome P-448 from 3-methylcholanthrene-induced rats, exhibited a considerably higher sensitivity towards CO (CO/O2 ratio approximately 1), well within the range for mixed-function oxidase reactions. It is concluded that the observed diminished CO sensitivity of microsomal benzo[a]pyrene hydroxylase in 3-methylcholanthrene- or 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats results from alterations in the composition and/or structural organization of the microenvironment of cytochrome P-448 in the endoplasmic reticulum in response to the inducing action of polycyclic aromatic hydrocarbons and related agents, and is not related to changes in the heme protein P-448 per se. The detailed nature of these changes is the subject of ongoing studies.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008297 Male Males
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D002248 Carbon Monoxide Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) Monoxide, Carbon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001189 Aryl Hydrocarbon Hydroxylases A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides. Microsomal Monooxygenases,Xenobiotic Monooxygenases,Hydroxylases, Aryl Hydrocarbon,Monooxygenases, Microsomal,Monooxygenases, Xenobiotic
D001579 Benzopyrene Hydroxylase A drug-metabolizing, cytochrome P-448 (P-450) enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1. Benzopyrene-3-Monooxygenase,Benzo(a)pyrene Hydroxylase,Benzo(a)pyrene Monooxygenase,Benzopyrene 3 Monooxygenase,Hydroxylase, Benzopyrene

Related Publications

D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
October 1979, Cancer research,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
October 1999, Molecular carcinogenesis,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
May 1982, Cancer research,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
May 1992, Xenobiotica; the fate of foreign compounds in biological systems,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
February 1992, Xenobiotica; the fate of foreign compounds in biological systems,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
July 1971, Archives of internal medicine,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
August 1976, The Journal of biological chemistry,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
July 1979, Cancer letters,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
March 1982, Biochemical pharmacology,
D Y Cooper, and H Schleyer, and O Rosenthal, and W Levin, and A Y Lu, and R Kuntzman, and A H Conney
September 1991, Carcinogenesis,
Copied contents to your clipboard!